Benefits consultants are fielding more questions about digestive health than ever before, and for good reason. The Business Group on Health has named GI a priority area for two years running, and the Peterson Health Technology Institute recently issued an independent assessment endorsing virtual GI care as an effective intervention for both payers and employers. Employer clients are starting to ask what this means for their population, their spend, and their vendor strategy. This guide gives consultants the framework to answer those questions with confidence, covering: why GI deserves a seat at the top-tier cost table, what separates credible vendors from marketing claims, and how to frame the ROI conversation in terms that resonate with benefits leaders.
GI has arrived on the consultant agenda. The Business Group on Health has flagged digestive health as a priority area. The Peterson Health Technology Institute has issued an independent assessment endorsing virtual GI care as an effective intervention for payers and employers. Employer clients are starting to ask questions. Here is the framework consultants need to answer them well.
Why GI is a legitimate top-four cost driver
Many consultants and their clients still think of GI as a second-tier cost category behind diabetes, cardiovascular, and musculoskeletal. The data does not support that ranking. The total annual burden of GI, liver, and pancreatic disease in the U.S. exceeds $136 billion. GI symptoms are the number one cause of treat-and-release ER visits. Two consecutive years of Business Group on Health priority designation reflect a growing recognition among large employer benefits leaders that GI has been systematically undercounted in claims analysis because it fragments across diagnostic codes rather than aggregating cleanly.
The two questions that define a credible vendor
When evaluating virtual GI solutions for employer clients, two questions cut through most of the market noise. First: is the outcomes data claims-based and independently validated? Vendor-produced ROI models are not a substitute for propensity-matched cohort analyses conducted by payers or actuarial firms. The programs with credible evidence have it published and available. Second: who is delivering the care? Programs that employ licensed GI clinicians who can diagnose, prescribe, and treat are categorically different from care navigation models that support patients alongside their existing care. The clinical capability of the care team determines what outcomes are achievable.
The enrollment variable most consultants underweight
A GI program deployed passively doesn’t generate enough enrollment to move population spend regardless of how strong the per-member clinical outcomes are. The enrollment variable that most consistently predicts population-level cost impact is cost-share waiver combined with proactive employee awareness outreach. Consultants recommending virtual GI solutions should make both conditions part of the implementation recommendation, not optional add-ons. Programs like Oshi Health have documented 20x higher enrollment when cost-share is waived and active outreach is deployed, with corresponding population-level GI PMPM reductions even in years when overall medical costs rose significantly.
How to frame the ROI conversation with employer clients
The ROI conversation in GI is unusually strong relative to most point solutions. Per-member all-cause cost savings of $6,000 to $11,000 annually, with returns on investment of 5x to 10x, are documented in independently validated studies. Population-level GI PMPM reductions of 7-8% have been achieved at 2-3% enrollment. For self-funded employers bearing the full cost of GI claims, these numbers are significant. The framing that resonates most with benefits leaders is not the per-member savings figure in isolation, but the population-level math: a small percentage of enrolled members generating enough individual savings to bend the cost curve for the entire covered population.
GI is not going to recede as a cost priority. The access shortage is structural. The clinical complexity of the conditions are real. And the workforce impact of unmanaged digestive disease, in absenteeism, presenteeism, and quality of life, is documented. Consultants who develop genuine expertise in this category now are positioning themselves ahead of what is becoming a standard employer benefits conversation.
